Open an account

Establishment Labs Holdings

ESTA · NASDAQ

$63.80+$0.28 (+0.44%)TodayMarket closed ·
Prev close $63.52

About ESTA

Establishment Labs Holdings, Inc. engages in the manufacturing and marketing of medical devices for aesthetic and reconstructive plastic surgery. The company employs 1,004 full-time employees The company went IPO on 2018-07-19. The firm is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

Employees
1,004
Headquarters
Alajuela, Alajuela
Listed
Jul 19, 2018
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
establishmentlabs.com

ESTA key statistics

Market cap
1.90B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
426.61K
Volume
346.34K
Open price
$63.14
High today
$64.94
Low today
$62.85
52 Week high
$97.59
52 Week low
$47.00

Establishment Labs Holdings (ESTA) at a glance

Establishment Labs Holdings (ESTA) last traded at $63.80, with a market cap of 1.90B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $62.85 and $64.94. The current price is 1.5% above the day's low and 1.8% below its high.

Volume so far is 346.34K shares, in line with the average of 426.61K shares a day.

Over the past year Establishment Labs Holdings has ranged from $47.00 to $97.59, and now sits 33% of the way up that range.

The average analyst price target is $103.36, 62.0% above the current price, from 8 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 8 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 12 analystsAvg $103.36
Low
$85.85
Now
$63.80
High
$122.85

ESTA news

  • Press releaseBusiness Wire

    Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

  • Press releaseBusiness Wire

    Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®

  • Press releaseBusiness Wire

    Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

  • Press releasePRNewswire

    A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

  • Press releaseGlobe Newswire

    The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

  • Press releaseBusiness Wire

    Establishment Labs® Reports Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6

  • Press releaseGlobe Newswire

    A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.